[HTML][HTML] Public values and plurality in health priority setting: what to do when people disagree and why we should care about reasons as well as choices

R Baker, H Mason, N McHugh, C Donaldson - Social Science & Medicine, 2021 - Elsevier
Abstract Context 'What does 'The Public'think?'is a question often posed by researchers and
policy makers, and public values are regularly invoked to justify policy decisions. Over time …

National Institute for Health and Care Excellence, social values and healthcare priority setting

P Littlejohns, K Chalkidou, AJ Culyer… - Journal of the Royal …, 2019 - journals.sagepub.com
On 1 April 2019, the National Institute for Health and Care Excellence was 20 years old. This
is an anniversary worth noting, if for no other reason than how remarkable it is for a National …

Science, politics and regulation: The trust-based approach to the demarcation problem

S John - Studies in History and Philosophy of Science Part A, 2021 - Elsevier
Drawing on literature on values in science and a case-study of UK cancer policy, this paper
argues for a novel account of the demarcation project in terms of trustworthiness. The first …

[HTML][HTML] Scoping review of international experience of a dedicated fund to support patient access to cancer drugs: policy implications for Thailand

P Luksameesate, O Nerapusee… - … Journal of Health …, 2024 - pmc.ncbi.nlm.nih.gov
Background: Access to high-cost cancer drugs is an unsolved problem globally. The
dedicated drugs fund is attractive and feasible. This study reviewed currently implemented …

The new and non-transparent Cancer drugs fund

EM Wood, DA Hughes - PharmacoEconomics, 2020 - Springer
The Cancer Drugs Fund (CDF) in England was established in 2011 to facilitate access to
cancer medicines that were not routinely available on the National Health Service (NHS). By …

Understanding the survival of NICE through a political science lens

DJ Hunter, P Littlejohns - NICE at 25, 2025 - taylorfrancis.com
For the last 25 years the National Institute for Health and Care Excellence (NICE) has been
a key part of the NHS. Despite numerous national re-organisations in which many …

Real-world assessment of cancer drugs using local data uploaded to the Systemic Anti-Cancer Therapy dataset in England

N Wadd, C Peedell, C Polwart - Clinical Oncology, 2022 - Elsevier
Abstract Aims In England, not all cancer drugs are routinely funded; new medicines are first
appraised by the National Institute for Health and Care Excellence. Funding can be …

Setting standards and monitoring quality in the NHS 1999–2013: a classic case of goal conflict

P Littlejohns, A Knight, A Littlejohns… - … journal of health …, 2017 - Wiley Online Library
Abstract 2013 saw the National Health Service (NHS) in England severely criticized for
providing poor quality despite successive governments in the previous 15 years …

The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics

A Mahalatchimy, A Faulkner - Regenerative medicine, 2017 - Taylor & Francis
Aim: This paper aims to map the trends and analyze key institutional dynamics that
constitute the policies for reimbursement of regenerative medicine (RM), especially in the …

[HTML][HTML] 英国癌症药物基金改革及对医保创新药支付政策的启示

刘跃华, 刘昭, 张萌, 郭武栋, 王耀羚… - 中国卫生政策 …, 2020 - journal.healthpolicy.cn
目的: 通过对英国癌症药物基金(Cancer Drugs Fund, CDF) 的形成背景, 运行机制及改革中优化
管理策略进行批判借鉴研究, 为中国创新药准入及管理政策的制定提供参考. 方法: 文献梳理 …